GlassScriptPhysician profile
David A Weber
NPI 1811921216
$1,485.98
in general payments reported to CMS, 2019-2025
13 companies · $40.57 in 2025
The $40.57 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $265 · 2021: $142 · 2022: $265 · 2023: $43.01 · 2024: $27.63 · 2025: $40.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $349.10 | 2021-2025 | |
| Amgen INC. | $278.89 | 2019-2021 | |
| Daiichi Sankyo INC. | $277.34 | 2019 | |
| Scilex Pharmaceuticals INC. | $144.59 | 2019 | |
| Pfizer INC. | $131.52 | 2019-2021 | |
| Boston Scientific Corporation | $82.29 | 2019-2023 | Spaceoar Vue System - 10ml |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.60 | 2019-2020 | |
| Allergan, INC. | $44.42 | 2020 | |
| Avanos Medical | $30.80 | 2020-2023 | Generator |
| Exact Sciences Corporation | $20.57 | 2025 | Cologuard Collection Kit |
| Ferring Pharmaceuticals INC. | $17.15 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.36 | 2019 | |
| Shionogi INC | $14.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.